Epilepsy, a chronic neurological disorder characterized by recurrent, unprovoked seizures, poses significant challenges to healthcare professionals. Despite the availability of numerous antiepileptic drugs (AEDs), about one-third of patients continue to experience uncontrolled seizures. This article aims to provide an update on the latest advancements in epilepsy management.
The last decade has seen the introduction of several new-generation AEDs. These drugs, such as perampanel and brivaracetam, have demonstrated improved efficacy and tolerability. They act on novel targets, thus providing additional therapeutic options for patients with drug-resistant epilepsy. However, their long-term safety profiles remain to be fully established.
Neuromodulation therapies, such as Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS), have emerged as effective adjunctive treatments for drug-resistant epilepsy. These therapies modulate neuronal activity, thereby reducing seizure frequency and severity. While invasive, they offer substantial benefits for patients who are not surgical candidates or have failed epilepsy surgery.
Advances in genetic testing have revolutionized the diagnostic approach to epilepsy. By identifying the genetic basis of certain epilepsy syndromes, healthcare professionals can provide more personalized treatment plans. These advancements also hold promise for the development of targeted therapies.
Telemedicine has emerged as a vital tool in epilepsy management, particularly amidst the COVID-19 pandemic. It allows for remote patient monitoring, reducing the need for hospital visits, and facilitating timely intervention. Moreover, it enables wider access to specialized epilepsy care, especially for patients in remote areas.
Advancements in epilepsy management are transforming the landscape of patient care. While challenges remain, these innovations offer hope for improved seizure control and quality of life for patients with epilepsy. Healthcare professionals must stay abreast of these developments to provide optimal patient care.
1.
Hypnotherapy may offer real benefits for cancer patient care
2.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
3.
Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.
4.
Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests
5.
Inadvertent lung cancer screening results are discussed in a new study.
1.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
2.
Cellular Mechanisms of Hematopoietic Stress Adaptation During Repeated Physiological Demand
3.
The Growing Crisis of Aplastic Anemia: A Call for Action
4.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
5.
Case Study: Advancing Preclinical Oncology Drug Development with Quantitative Systems Pharmacology
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
3.
Early warning sings of camcer that need medical attention
4.
From Guidelines to Practice: Hematology
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation